Furthermore, the BCR (aka Immunoglobulins) repertoire analysis demonstrated a skewing of IGHV gene usage in WAS patients, with higher level of clonal expansions [7]. This evidence concerns the gene BCR and Wiskott-Aldrich syndrome.